Skip to main content
KYMR logo

KYMR · Kymera Therapeutics, Inc. · Analyst Estimates

Track KYMR — free
$107.39 -2.73 (-2.48%) At close · Oct 2
Market Cap
$9.31B
Shares
83.15M
Volume · Oct 2 870.21K Avg daily vol (3M) 688.91K

Analyst Estimates

Compare analyst forecasts for Kymera Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-04 01:14 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.29
-3.83866
-3.13
—
-3.78466
-3.51163
-3.83866
-3.51558
— — — —
EPS
analysts
Publication date not stated
— — —
20
— — — —
11
12
3
3
Revenue
USD
Publication date not stated
97000000
105029850
139000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
22
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-7.55
-5.0991
-3.54342
—
-4.9351
-4.35627
-5.0991
-4.34614
— — — —
EPS
analysts
Publication date not stated
— — —
20
— — — —
2
1
1
0
Revenue
USD
Publication date not stated
-13000000
40205460
97931000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
21
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.47
-1.26142
-1.04
—
-1.23742
-1.02678
-1.25044
-1.02625
— — — —
EPS
analysts
Publication date not stated
— — —
20
— — — —
11
12
2
2
Revenue
USD
Publication date not stated
-1000000
3103270
20000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
19
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.52
-1.27483
-0.99
—
-1.25588
-1.0264
-1.26121
-1.02798
— — — —
EPS
analysts
Publication date not stated
— — —
19
— — — —
11
12
2
2
Revenue
USD
Publication date not stated
-1000000
3381920
20000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —
Key facts CIK 1815442 CUSIP 501575104 13F (30d) 6 filings 6 filers Visit website Investor relations